Business Information
The group's principal activities are to create solutions that redefine the early detection and clinical management of cancer. The group operates through two divisions: commercial operations, through which it manages the market introduction, sales, service, manufacturing and development of products. Tripath oncology is the other division, through which it manages to develop molecular diagnostic and pharmacogenomic tests for cancer. Tripath oncology has not materialized revenues so far. The group's trademarks include autocyte quic (R), autopap (R), cytorich (R), imagetiter (R), papmap (R), prepmate (R), slidewizard (R), and tripath imaging (r). The group has operations located at the United States, Australia and Belgium.
|
|
|
Year |
Sales |
Net Income |
| 2005 | 85,961 | 6,500 | | 2004 | 68,504 | 605 | | 2003 | 53,764 | (8,538)
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
